Designing of CD8⁺ and CD8⁺-overlapped CD4⁺ epitope vaccine by targeting late and early proteins of human papillomavirus

References

• OhlenschlägerOSeibothTZengerlingHSolution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7Oncogene200625445953595916636661
   PubMed Web of Science ®Google Scholar
• de SanjoseSQuintWGVAlemanyLRetrospective International Survey and HPV Time Trends Study GroupHuman papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyLancet Oncol201011111048105620952254
   PubMed Web of Science ®Google Scholar
• McbrideAAThe Papillomavirus E2 proteinsVirology20134451–2577923849793
   PubMed Web of Science ®Google Scholar
• BoganiGLeone Roberti MaggioreUSignorelliMThe role of human papillomavirus vaccines in cervical cancer: Prevention and treatmentCrit Rev Oncol Hematol2018122929729458794
   PubMed Web of Science ®Google Scholar
• MightyKKLaiminsLAThe role of human papillomaviruses in oncogenesisRecent Results Cancer Res201419313514824008297
   PubMedGoogle Scholar
• GrahamSVHuman papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapiesFuture Microbiol20105101493150621073310
   PubMed Web of Science ®Google Scholar
• HartyJTTvinnereimARWhiteDWCD8+ T cell effector mechanisms in resistance to infectionAnnu Rev Immunol200018127530810837060
   PubMed Web of Science ®Google Scholar
• GaoGFJakobsenBKMolecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptorImmunol Today2000211263063611114424
   PubMedGoogle Scholar
• RochePAFurutaKThe ins and outs of MHC class II-mediated antigen processing and presentationNat Rev Immunol201515420321625720354
   PubMed Web of Science ®Google Scholar
• ShcharanskyMTothIPeptide-based synthetic vaccinesChem Sci20167284285428791117
   PubMed Web of Science ®Google Scholar
• PetroskyEBocchiniJAJrHaririSCenters for Disease Control and Prevention (CDC)Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practicesMMWR Morb Mortal Wkly Rep2015641130030425811679
   PubMed Web of Science ®Google Scholar
• WainGThe human papillomavirus (HPV) vaccine, HPV related diseases and cervical cancer in the post-reproductive yearsMaturitas201065320520920036786
   PubMed Web of Science ®Google Scholar
• PandhiDSonthaliaSHuman papilloma virus vaccines: Current scenarioIndian J Sex Transm Dis20113227585
   Google Scholar
• WakerleyBRYukiNPharyngeal-cervical-brachial variant of Guillain-Barre syndromeJ Neurol Neurosurg Psychiatry201485333934423804237
   PubMed Web of Science ®Google Scholar
• UngerZMaitraAKohnJDevaskarSSternLPatelAKnowledge of HPV and HPV Vaccine among Women Ages 19 to 26Women’s Health Issues201525545846226212317
   PubMed Web of Science ®Google Scholar
• TjalmaWADepuydtCEDon’t forget HPV-45 in cervical cancer screeningAm J Clin Pathol2012137116116222180491
   PubMed Web of Science ®Google Scholar
• MuñozNBoschFXde SanjoséSInternational Agency for Research on Cancer Multicenter Cervical Cancer Study GroupEpidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med2003348651852712571259
   PubMed Web of Science ®Google Scholar
• SasagawaTMaehamaTIdetaKIrieTFujiko Itoh J-HERS Study GroupPopulation-based study for human papillomavirus (HPV) infection in young women in Japan: A multicenter study by the Japa-nese human papillomavirus disease education research survey group (J-HERS)J Med Virol201688232433526147986
   PubMed Web of Science ®Google Scholar
• SmithJSLindsayLHootsBHuman papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis updateInt J Cancer2007121362163217405118
   PubMed Web of Science ®Google Scholar
• FélixAAlemanyLTousSde SanjoséSBoschFXHPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005Papillomavirus Res20162414529074184
   PubMed Web of Science ®Google Scholar
• BoschFXLorinczAMuñozNMeijerCJShahKVThe causal relation between human papillomavirus and cervical cancerJ Clin Pathol200255424426511919208
   PubMed Web of Science ®Google Scholar
• de VilliersEMFauquetCBrokerTRBernardHUzur HausenHClassification of papillomavirusesVirology20043241172715183049
   PubMed Web of Science ®Google Scholar
• NaghashfarZSRosensheinNBLorinczATBuscemaJShahKVCharacterization of human papillomavirus type 45, a new type 18-related virus of the genital tractJ Gen Virol198768Pt 12307330792826649
   PubMed Web of Science ®Google Scholar
• ChenZSchiffmanMHerreroREvolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70PLoS One201388e7256523977318
   PubMed Web of Science ®Google Scholar
• AwuaAKSackeySTOseiYDAsmahRHWireduEKPrevalence of human papillomavirus genotypes among women with cervical cancer in GhanaInfect Agent Cancer2016111426816527
   PubMed Web of Science ®Google Scholar
• StamenkovićMKneževićAKneževićIHigh-risk human papilloma virus genotypes in cervical carcinoma of Serbian women: Distribution and association with pathohistological findingsBiologicals201644541241627461126
   PubMed Web of Science ®Google Scholar
• GodínezJMHeidemanDAGheitTDifferential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58Infect Genet Evol2013139610423022714
   PubMed Web of Science ®Google Scholar
• AzizHIqbalHMahmoodHHuman papillomavirus infection in females with normal cervical cytology: Genotyping and phylogenetic analysis among women in Punjab, PakistanInt J Infect Dis201866838929138009
   PubMed Web of Science ®Google Scholar
• DjigmaFWOuédraogoCKarouDSPrevalence and genotype characterization of Human Papillomaviruses among HIV-seropositive in Ouagadougou, Burkina FasoActa Trop2011117320220621167118
   PubMed Web of Science ®Google Scholar
• HhXWangKFengXJPrevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysisOncotarget2018920153861539729632652
   PubMedGoogle Scholar
• BastoDLVidalJPPontesVBGenetic diversity of human papillomavirus types 35, 45 and 58 in cervical cancer in BrazilArch Virol201716292855286028597068
   PubMed Web of Science ®Google Scholar
• DasDRaiAKKatakiACNested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North- East IndiaAsian Pac J Cancer Prev201314278579023621238
   PubMedGoogle Scholar
• Amaro-FilhoSMPereira ChavesCBFelixSPBastoDLde AlmeidaLMMoreiraMAMHPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancerPapillomavirus Res2018517217929649654
   PubMed Web of Science ®Google Scholar
• AwuaAKAdanuRMKWireduEKUnique LCR variations among lineages of HPV16, 18 and 45 isolates from women with normal cervical cytology in GhanaVirol J20171418528431571
   PubMed Web of Science ®Google Scholar
• GuanPHowell-JonesRLiNHuman papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancerInt J Cancer2012131102349235922323075
   PubMed Web of Science ®Google Scholar
• Usman MirzaMRafiqueSAliATowards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteinsSci Rep2016613731327934901
   PubMed Web of Science ®Google Scholar
• PatronovADoytchinovaIT-cell epitope vaccine design by immunoinformaticsOpen Biol20133112013923303307
   PubMed Web of Science ®Google Scholar
• KatherAFerraraANonnMIdentification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccinationInt J Cancer2003104334535312569558
   PubMed Web of Science ®Google Scholar
• KimSChungHWLeeK-RLimJBIdentification of novel epitopes from human papillomavirus type 18 E7 that can sensitize PBMCs of multiple HLA class I against human cervical cancerJ Transl Med201412122925141788
   PubMed Web of Science ®Google Scholar
• SinghKPVermaNAkhoonBASequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains3 Biotech20166139
   Google Scholar
• ChenzhangYWenQDingXIdentification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest ChinaImmunol Lett2017181263027693214
   PubMed Web of Science ®Google Scholar
• KhanAJunaidMKaushikACComputational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approachesPLoS One2018135e019648429715318
   PubMed Web of Science ®Google Scholar
• PetroskyEBocchiniJAJrHaririSCenters for Disease Control and Prevention (CDC)Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practicesMMWR Morb Mortal Wkly Rep2015641130030425811679
   PubMed Web of Science ®Google Scholar
• UniprotConsortium TUniProt: the universal protein knowledgebaseNucleic Acids Res2018465269929425356
   PubMed Web of Science ®Google Scholar
• DoytchinovaIAFlowerDRVaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccinesBMC Bioinformatics200781417207271
   PubMed Web of Science ®Google Scholar
• LarsenMVLundegaardCLamberthKBuusSLundONielsenMLarge-scale validation of methods for cytotoxic T-lymphocyte epitope predictionBMC Bioinformatics20078142417973982
   PubMed Web of Science ®Google Scholar
• TenzerSPetersBBulikSModeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I bindingCell Mol Life Sci20056291025103715868101
   PubMed Web of Science ®Google Scholar
• CalisJJMaybenoMGreenbaumJAProperties of MHC class I presented peptides that enhance immunogenicityPLoS Comput Biol2013910e100326624204222
   PubMed Web of Science ®Google Scholar
• BuiHHSidneyJLiWFussederNSetteADevelopment of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccinesBMC Bioinformatics20078136117897458
   PubMed Web of Science ®Google Scholar
• BuiHHSidneyJDinhKSouthwoodSNewmanMJSetteAPredicting population coverage of T-cell epitope-based diagnostics and vaccinesBMC Bioinformatics20067115316545123
   PubMed Web of Science ®Google Scholar
• KaurHGargARaghavaGPPEPstr: a de novo method for tertiary structure prediction of small bioactive peptidesProtein Pept Lett200714762663117897087
   PubMed Web of Science ®Google Scholar
• ShenYMaupetitJDerreumauxPTufféryPImproved PEP-FOLD approach for peptide and miniprotein structure predictionJ Chem Theory Comput201410104745475826588162
   PubMed Web of Science ®Google Scholar
• KelleyLAMezulisSYatesCMWassMNSternbergMJThe Phyre2 web portal for protein modeling, prediction and analysisNat Protoc201510684585825950237
   PubMed Web of Science ®Google Scholar
• PanditSBZhangYSkolnickJTASSER-Lite: an automated tool for protein comparative modelingBiophys J200691114180419016963505
   PubMed Web of Science ®Google Scholar
• Schneidman-DuhovnyDInbarYNussinovRWolfsonHJPatchDock and SymmDock: servers for rigid and symmetric dockingNucleic Acids Res200533Web ServerW363W36715980490
   PubMed Web of Science ®Google Scholar
• MashiachESchneidman-DuhovnyDAndrusierNNussinovRWolfsonHJFireDock: a web server for fast interaction refinement in molecular dockingNucleic Acids Res200836Web ServerW229W23218424796
   PubMed Web of Science ®Google Scholar
• HuangCCMengECMorrisJHPettersenEFFerrinTEEnhancing UCSF Chimera through web servicesNucleic Acids Res201442W1W478W48424861624
   PubMed Web of Science ®Google Scholar
• WangPSidneyJDowCMothéBSetteAPetersBA systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approachPLoS Comput Biol200844e100004818389056
   PubMed Web of Science ®Google Scholar
• DhandaSKVirPRaghavaGPDesigning of interferon-gamma inducing MHC class-II bindersBiol Direct2013813024304645
   PubMed Web of Science ®Google Scholar
• SahaSRaghavaGPPrediction of continuous B-cell epitopes in an antigen using recurrent neural networkProteins2006651404816894596
   PubMed Web of Science ®Google Scholar
• DimitrovINanevaLDoytchinovaIBangovIAllergenFP: allergenicity prediction by descriptor fingerprintsBioinformatics201430684685124167156
   PubMed Web of Science ®Google Scholar
• LuccheseGStufanoAKanducDProteome-guided search for influenza A B-cell epitopesFEMS Immunol Med Microbiol2009571889219659580
   PubMedGoogle Scholar
• ChenCLiZHuangHSuzekBEWuCHUniProt ConsortiumA fast Peptide Match service for UniProt KnowledgebaseBioinformatics201329212808280923958731
   PubMed Web of Science ®Google Scholar
• NilgesKHöhnHPilchHHuman papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 proteinJ Virol20037795464547412692247
   PubMed Web of Science ®Google Scholar
• RomanczukHHowleyPMDisruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacityProc Natl Acad Sci1992897315931631313584
   PubMed Web of Science ®Google Scholar
• GaoLJGuPQZhaoWThe role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activationJ Transl Med201311111823651874
   PubMed Web of Science ®Google Scholar
• ZhangEFengXLiuFZhangPLiangJTangXRoles of PI3K/ Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cellsPLoS One201497e10344025058399
   PubMed Web of Science ®Google Scholar
• SubbaramaiahKDannenbergAJCyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchangeCancer Res20076783976398517440114
   PubMed Web of Science ®Google Scholar
• ZhouYWeiYZhuJGRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancersPLoS One201167e2206521765936
   PubMed Web of Science ®Google Scholar
• XuBChotewutmontriSWolfSMultiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical CarcinomasPLoS One201386e6669323824673
   PubMed Web of Science ®Google Scholar
• DoorbarJQuintWBanksLThe Biology and Life-Cycle of Human PapillomavirusesVaccine2012305F55F7023199966
   PubMed Web of Science ®Google Scholar
• SunJXiongJZhenYChenZLZhangHP53 and PCNA is Positively Correlated with HPV Infection in Laryngeal Epitheliopapillomatous Lesions in Patiets with Different Ethnic Backgrounds in XinjiangAsian Pac J Cancer Prev201213115439544423317197
   PubMedGoogle Scholar
• Vazquez-VegaSSanchez-SuarezLPAndrade-CruzRRegulation of p14ARF expression by HPV-18 E6 variantsJ Med Virol20138571215122123918540
   PubMed Web of Science ®Google Scholar
• KimSMLeeJULeeDWKimMJLeeHNThe prognostic signifi cance of p16, Ki-67, p63, and CK17 expression determined by immunohistochemical staining in cervical intraepithelial neoplasia 1Korean J Obstet Gynecol2011544184191
   Google Scholar
• FunahashiAMorohashiMKitanoHTanimuraNCellDesigner: a process diagram editor for gene-regulatory and biochemical networksBIOSILICO200315159162
   Google Scholar
• KaushikACKumarADwivediVDDeciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology ApproachMol Neurobiol20185543224323628478508
   PubMed Web of Science ®Google Scholar
• HoopsSSahleSGaugesRCOPASI–a COmplex PAthway SImulatorBioinformatics200622243067307417032683
   PubMed Web of Science ®Google Scholar
• FitzmauriceCDickerDPainAThe Global Burden of Cancer 2013JAMA Oncol20151450552726181261
   PubMed Web of Science ®Google Scholar
• ZhaoMWeiD-QRare diseases: Drug discovery and informatics resourceInterdiscip Sci201810119520429094320
   PubMed Web of Science ®Google Scholar
• KamthaniaMSharmaDKScreening and structure-based modeling of T-cell epitopes of Nipah virus proteome: an immunoinformatic approach for designing peptide-based vaccine3 Biotech201556877882
   Google Scholar
• MoosaviFMohabatkarHMohsenzadehSComputer-aided analysis of structural properties and epitopes of Iranian HPV-16 E7 oncoproteinInterdiscip Sci20102436737221153780
   PubMed Web of Science ®Google Scholar
• MuderspachLWilczynskiSRomanLA phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positiveClin Cancer Res2000693406341610999722
   PubMed Web of Science ®Google Scholar
• ElemansMFlorinsAWillemsLAsquithBRates of CTL killing in persistent viral infection in vivoPLoS Comput Biol2014104e100353424699260
   PubMed Web of Science ®Google Scholar
• Bassani-SternbergMPletscher-FrankildSJensenLJMannMMass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentationMol Cell Proteomics201514365867325576301
   PubMed Web of Science ®Google Scholar
• LorenteEGarcíaRLópezDAllele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cellsJ Biol Chem201128644380543805921914809
   PubMed Web of Science ®Google Scholar
• BrusicVBajicVBPetrovskyNComputational methods for prediction of T-cell epitopes – a framework for modelling, testing, and applicationsMethods200434443644315542369
   PubMed Web of Science ®Google Scholar
• MeydanCOtuHHSezermanOUPrediction of peptides binding to MHC class I and II alleles by temporal motif miningBMC Bioinformatics201314Suppl 2S13
   Web of Science ®Google Scholar
• SlifkaMKWhittonJLAntigen-Specific Regulation of T Cell–Mediated Cytokine ProductionImmunity200012545145710843378
   PubMed Web of Science ®Google Scholar
• GhanekarSANomuraLESuniMAPickerLJMaeckerHTMainoVCGamma Interferon Expression in CD8+ T Cells Is a Marker for Circulating Cytotoxic T Lymphocytes That Recognize an HLA A2-Restricted Epitope of Human Cytomegalovirus Phosphoprotein pp65Clin Diagn Lab Immunol20018362863111329470
   PubMedGoogle Scholar
• KaliffMSorbeBMordhorstLBHeleniusGKarlssonMGLillsunde-LarssonGFindings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapyOncotarget2018927187861879629721161
   PubMedGoogle Scholar
• BadialRMDiasMCStuquiBDetection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infectionMedicine (Baltimore)20189714e954529620669
   PubMed Web of Science ®Google Scholar
• SabahSNGaziMASthityRADesigning of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 IsolatesInterdiscip Sci201810225126027640170
   PubMed Web of Science ®Google Scholar
• CliffordGMTullySFranceschiSCarcinogenicity of human papilloma-virus (HPV) types in HIV-positive women: A meta-analysis from HPV infection to cervical cancerClin Infect Dis20176491228123528199532
   PubMed Web of Science ®Google Scholar
• ChatterjeeSChattopadhyayASamantaLPanigrahiPHPV and Cervical Cancer Epidemiology - Current Status of HPV Vaccination in IndiaAsian Pac J Cancer Prev20161783663367327644600
   PubMedGoogle Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• MonieAHungCFRodenRWuTCCervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancerBiologics20082197105
   PubMedGoogle Scholar
• GreenbaumJAAndersenPHBlytheMTowards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction toolsJ Mol Recognit2007202758217205610
   PubMed Web of Science ®Google Scholar
• de OliveiraLMFMoraleMGChavesAADesign, immune responses and anti-tumor potential of an HPV16 E6E7 multi-epitope vaccinePLoS One2015109e013868626390407
   PubMed Web of Science ®Google Scholar
• de JongAO’NeillTKhanAYEnhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccineVaccine20022029–303456346412297390
   PubMed Web of Science ®Google Scholar
• JonesEYMHC class I and class II structuresCurr Opin Immunol19979175799039778
   PubMed Web of Science ®Google Scholar
• SercarzEEMaverakisEMhc-guided processing: binding of large antigen fragmentsNat Rev Immunol20033862162912974477
   PubMed Web of Science ®Google Scholar
• PaoliniFCurzioGCordeiroMNHPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapyHum Vaccin Immunother201713229129727929754
   PubMed Web of Science ®Google Scholar
• BristolJAOrsiniCLindingerPThalhamerJAbramsSIIdentification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunizationCell Immunol20002052738311104579
   PubMed Web of Science ®Google Scholar